Investigation of the Prognostic Value of Patterns of Genomic Alterations or Protein Expression in Patients With Operated Early Breast Cancer

Plain-language summary

This study investigates the prognostic value of patterns of genomic alterations or protein expression in patients with operated early breast cancer. It does not involve any drug and can include women older than 18 with histologically confirmed epithelial breast cancer and good general health status. It is a study without an assigned phase and is active but not currently recruiting participants.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Active, not recruiting

Sponsor

Hellenic Cooperative Oncology Group

Start date

1/31/1997

Estimated completion

10/15/2026

Countries

Greece

Related genes

Locations

• Athens, Greece

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Women with histologically confirmed epithelial breast cancer
* Age \>18 years
* Pathological stage
* Eastern Cooperative Oncology Group performance status 0-1
* Normal cardiac function and adequate bone marrow, hepatic and renal function.